DCOY:NASDAQ, Decoy Therapeutics Inc Com Par $0.0001 (New)

DCOY stock overview

Decoy Therapeutics Inc Com Par $0.0001 (New) (DCOY:NASDAQ) closed at $0.901 on November 16, 2026, down 7.61% on the day. The stock trades 94.7% below its 52-week high of $16.92 and 0.1% above its 52-week low of $0.900. Over the past year, it lost 91.2%. Decoy Therapeutics Inc Com Par $0.0001 (New) is part of the Health Care sector.

Key figures

Price
$0.901
Day change
-7.61%
Volume
28,980
Average volume
2,163,753
Market cap
2M+
52-week range
$0.900 – $16.92
50-day average
$1.78
200-day average
$5.07

Price action over the past year

In 252 trading sessions since November 14, 2025, DCOY closed higher on 99 days (39%). Its best day was June 29, 2026 (+73.79%) and its worst was January 14, 2026 (-30.40%). The stock moved 10% or more in a single session 32 times. It opened at least 5% above the previous day's high 5 times.

Recent signals

DCOY news

About Decoy Therapeutics Inc Com Par $0.0001 (New)

Decoy is a preclinical-stage biotechnology company that is leveraging machine learning and AI tools alongside high-speed synthesis techniques to rapidly design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs. The Company's initial pipeline is focused on respiratory viruses and GI cancers. Decoy has attracted financing from institutional investors as well as significant capital from the Massachusetts Life Sciences Seed Fund, the Google AI startup program and the NVIDIA Inception program, among other sources. The Company has also received QuickFire Challenge award funding provided by BARDA through BLUE KNIGHT¿, a collaboration between Johnson & Johnson Innovation - JLABS and BARDA within the Administration for Strategic Preparedness and Response.

Similar stocks

Find more stocks like DCOY with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.